Contact

All Stories

  1. Insomnia and Mental Health Outcomes After Catastrophic Disasters: A Cross-Sectional Study Examining the Long-Term Effects of the Beirut Port Explosion

    Article • Neuropsychiatric Disease and Treatment, September 2025, Taylor & Francis

    Dr. Firas Kobeissy

  2. Identification of Distinct Biological Groups of Patients With Cryptogenic NORSE via Inflammatory Profiling

    Article • Neurology Neuroimmunology & Neuroinflammation, July 2025, Wolters Kluwer Health

    Dr. Firas Kobeissy

  3. Alteration of Metabolic Profile in Patients with Narcolepsy Type 1

    Article • Metabolites, June 2025, MDPI AG

    Dr. Firas Kobeissy

  4. Exploring the Anti-Leukemic Effect of the Synthetic Retinoid ST1926 on Malignant T Cells: A Comprehensive Proteomics Approach

    Article • International Journal of Molecular Sciences, May 2025, MDPI AG

    Dr. Firas Kobeissy

  5. Inhibition of furin in CAR macrophages directs them toward a proinflammatory phenotype and enhances their antitumor activities

    Article • Cell Death and Disease, December 2024, Springer Science + Business Media

    Dr. Firas Kobeissy

  6. Exploiting blood-based biomarkers to align preclinical models with human traumatic brain injury

    Article • Brain, November 2024, Oxford University Press (OUP)

    Dr. Firas Kobeissy

  7. The impact of posttraumatic stress disorder and head injury on reactive and appetitive aggression in adult Syrian refugees in Lebanon.

    Article • Psychological Trauma Theory Research Practice and Policy, October 2024, American Psychological Association (APA)

    Dr. Firas Kobeissy

  8. Emerging understandings of the role of exosomes in atherosclerosis

    Article • Journal of Cellular Physiology, October 2024, Wiley

    Dr. Firas Kobeissy

  9. Contemporary Update on Clinical and Experimental Prostate Cancer Biomarkers: A Multi-Omics-Focused Approach to Detection and Risk Stratification

    Article • Biology, September 2024, MDPI AG

    Dr. Firas Kobeissy

  10. Revisiting HER2 in Prostate Cancer from an Inclusive Perspective: From Biomarkers to Omics

    Article • Cancers, September 2024, MDPI AG

    Dr. Firas Kobeissy

  11. Vitamin D Deficiency Does Not Affect Cognition and Neurogenesis in Adult C57Bl/6 Mice

    Article • Nutrients, September 2024, MDPI AG

    Dr. Firas Kobeissy

  12. Western diet induces mild metabolic impairment and aggravates neuropathology in an experimental mouse model of traumatic brain injury

    Article • Journal of Neurorestoratology, September 2024, Tsinghua University Press

    Prof Yehia Mechref, Dr. Firas Kobeissy

  13. 1,25-Dihydroxyvitamin D3 Suppresses Prognostic Survival Biomarkers Associated with Cell Cycle and Actin Organization in a Non-Malignant African American Prostate Cell Line

    Article • Biology, May 2024, MDPI AG

    Dr. Firas Kobeissy

  14. Cultural assimilation of adult Syrian refugees in Lebanon: Effect modification by religiosity and sex on the relation between cultural adversities and common mental health disorders.

    Article • Psychological Trauma Theory Research Practice and Policy, April 2024, American Psychological Association (APA)

    Dr. Firas Kobeissy

  15. MicroRNAs as biomarkers of brain injury in neonatal encephalopathy: an observational cohort study

    Article • Scientific Reports, March 2024, Springer Science + Business Media

    Dr. Firas Kobeissy

  16. Functional Selection of Tau Oligomerization‐Inhibiting Aptamers

    Article • Angewandte Chemie, March 2024, Wiley

    Dr. Firas Kobeissy

  17. Functional Selection of Tau Oligomerization‐Inhibiting Aptamers

    Article • Angewandte Chemie, March 2024, Wiley

    Dr. Firas Kobeissy

  18. Aptamer Technologies in Neuroscience, Neuro-Diagnostics and Neuro-Medicine Development

    Article • Molecules, March 2024, MDPI AG

    Dr. Firas Kobeissy

  19. Transcriptomic Signatures of Neuronally Derived Extracellular Vesicles Reveal the Presence of Olfactory Receptors in Clinical Samples from Traumatic Brain Injury Patients

    Article • International Journal of Molecular Sciences, February 2024, MDPI AG

    Dr. Firas Kobeissy

  20. Determination of Medicago orbicularis Antioxidant, Antihemolytic, and Anti-Cancerous Activities and Its Augmentation of Cisplatin-Induced Cytotoxicity in A549 Lung Cancer Cells

    Article • Plants, February 2024, MDPI AG

    Dr. Firas Kobeissy

  21. The game changer: UCH-L1 and GFAP-based blood test as the first marketed in vitro diagnostic test for mild traumatic brain injury

    Article • Expert Review of Molecular Diagnostics, January 2024, Taylor & Francis

    Dr. Firas Kobeissy

  22. The Use of Biofluid Markers to Evaluate the Consequences of Sport-Related Subconcussive Head Impact Exposure: A Scoping Review

    Article • Sports Medicine - Open, January 2024, Springer Science + Business Media

    Dr. Firas Kobeissy

  23. Estrogen Receptor and the Gender Bias in Raynaud’s Phenomenon

    Article • Current Medicinal Chemistry, January 2024, Bentham Science Publishers

    Dr. Firas Kobeissy

  24. Traumatic Brain Injury and Opioids: Twin Plagues of the Twenty-First Century

    Article • Biological Psychiatry, January 2024, Elsevier

    Dr. Firas Kobeissy

  25. Biomaterials in Traumatic Brain Injury: Perspectives and Challenges

    Article • Biology, December 2023, MDPI AG

    Dr. Firas Kobeissy

  26. Functional connectivity, tissue microstructure and T2 at 11.1 Tesla distinguishes neuroadaptive differences in two traumatic brain injury models in rats: A Translational Outcomes Project in NeuroTrauma (TOP-NT) UG3 phase study

    Article • December 2023, Cold Spring Harbor Laboratory Press

    Dr. Firas Kobeissy

  27. Translating from mice to humans: using preclinical blood-based biomarkers for the prognosis and treatment of traumatic brain injury

    Article • December 2023, Cold Spring Harbor Laboratory Press

    Dr. Firas Kobeissy

  28. Sleep Disruption in a Mouse Model of Chronic Traumatic Brain Injury

    Article • November 2023, Cold Spring Harbor Laboratory Press

    Dr. Firas Kobeissy

  29. Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis

    Article • Cancers, November 2023, MDPI AG

    Dr. Firas Kobeissy

  30. Unveiling a Biomarker Signature of Meningioma: the Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis

    Article • November 2023, MDPI AG

    Dr. Firas Kobeissy

  31. LC-MS/MS Quantitation of HILIC-Enriched N-glycopeptides Derived from Low-Abundance Serum Glycoproteins in Patients with Narcolepsy Type 1

    Article • Biomolecules, October 2023, MDPI AG

    Dr. Firas Kobeissy

  32. Biomaterials in Traumatic Brain Injury: Challenges and Perspectives

    Article • October 2023, MDPI AG

    Dr. Firas Kobeissy

  33. <em>Medicago orbicularis</em> Has Antioxidant, Antihemolytic, and Anti-cancerous Activities and Augments Cisplatin-Induced Cytotoxicity in A549 Lung Cancer Cells

    Article • September 2023, MDPI AG

    Dr. Firas Kobeissy

  34. The Antitumor Effect of the DNA Polymerase Alpha Inhibitor ST1926 in Glioblastoma: A Proteomics Approach

    Article • International Journal of Molecular Sciences, September 2023, MDPI AG

    Dr. Firas Kobeissy

  35. Biomaterials in Traumatic Brain Injury: Challenges and Perspectives

    Article • September 2023, MDPI AG

    Dr. Firas Kobeissy

  36. Traumatic Brain Injury in Cameroon: A Prospective Observational Study in a Level I Trauma Centre

    Article • Medicina, August 2023, MDPI AG

    andrew maas, Dr. Firas Kobeissy

  37. Unveiling a Biomarker Signature of Meningioma: the Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis

    Article • August 2023, MDPI AG

    Dr. Firas Kobeissy

  38. Serum Biomarker Concentrations upon Admission in Acute Traumatic Brain Injury: Associations with TBI Severity, Toxoplasma gondii Infection, and Outcome in a Referral Hospital Setting in Cameroon

    Article • NeuroSci, July 2023, MDPI AG

    andrew maas, Dr. Firas Kobeissy

  39. Serum Biomarker Concentrations on Admission in Acute Traumatic Brain Injury: Associations with, TBI Severity, <em>Toxoplasma gondii </em>Infection and Outcome in a Referral Hospital Setting, Cameroon

    Article • May 2023, MDPI AG

    andrew maas, Dr. Firas Kobeissy

  40. Association between Cerebrospinal Fluid and Serum Biomarker Levels and Diagnosis, Injury Severity, and Short-Term Outcomes in Patients with Acute Traumatic Spinal Cord Injury

    Article • Diagnostics, May 2023, MDPI AG

    Dr. Firas Kobeissy

  41. Inflammation and hypertension: Underlying mechanisms and emerging understandings

    Article • Journal of Cellular Physiology, April 2023, Wiley

    Dr. Firas Kobeissy

  42. LC-MS/MS-Based Proteomics Approach for the Identification of Candidate Serum Biomarkers in Patients with Narcolepsy Type 1

    Article • Biomolecules, February 2023, MDPI AG

    Dr. Firas Kobeissy

  43. Posttraumatic stress disorder among the Lebanese population and Syrian refugees: A systematic review.

    Article • Psychological Trauma Theory Research Practice and Policy, January 2023, American Psychological Association (APA)

    Dr. Firas Kobeissy

  44. Receptor tyrosine kinases in major depressive disorder

    Article • January 2023, Elsevier

    Dr. Firas Kobeissy

  45. Concomitant Guillain–Barré Syndrome and COVID-19: A Meta-Analysis of Cases

    Article • Medicina, December 2022, MDPI AG

    Dr. Firas Kobeissy

  46. Characterization of Calpain and Caspase-6-Generated Glial Fibrillary Acidic Protein Breakdown Products Following Traumatic Brain Injury and Astroglial Cell Injury

    Article • International Journal of Molecular Sciences, August 2022, MDPI AG

    Dr. Firas Kobeissy

  47. Neurological Outcomes Following Mitoquinone Supplementation in Mice, 3 and 7 Days Post Repeated Mild Traumatic Brain Injury

    Article • July 2022, MDPI AG

    Dr. Firas Kobeissy

  48. Characterization of Calpain and Caspase-6 Generated Glial Fibrillary Acidic Protein Breakdown Products Following Traumatic Brain Injury and Astroglial Cell Injury

    Article • June 2022, MDPI AG

    Dr. Firas Kobeissy

  49. Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating Computational Biology and Clinical Validation

    Article • Cancers, June 2022, MDPI AG

    Professor Hassan M. E. Azzazy, Dr. Firas Kobeissy

  50. Cannabinoids and Myocardial Ischemia: Novel insights, Updated Mechanisms, and Implications for Myocardial Infarction

    Article • Current Medicinal Chemistry, April 2022, Bentham Science Publishers

    Suzanne Nasser, Dr. Firas Kobeissy, Karim Seif El Dahan

  51. The effect of clopidogrel and aspirin on the severity of traumatic brain injury in a rat model

    Article • Neurochemistry International, March 2022, Elsevier

    Wael Mohamed, Dr. Firas Kobeissy

  52. Glycomic and Glycoproteomic Techniques in Neurodegenerative Disorders and Neurotrauma: Towards Personalized Markers

    Article • Cells, February 2022, MDPI AG

    Dr. Firas Kobeissy

  53. Gasoline fume inhalation induces apoptosis, inflammation, and favors Th2 polarization in C57BL/6 mice

    Article • Journal of Applied Toxicology, January 2022, Wiley

    Dr. Firas Kobeissy

  54. Mitoquinone Helps Combat the Neurological, Cognitive, and Molecular Consequences of Open Head Traumatic Brain Injury at Chronic Time Point

    Article • Biomedicines, January 2022, MDPI AG

    Dr. Firas Kobeissy

  55. Co-Expression Analysis of microRNAs and Proteins in Brain of Alzheimer’s Disease Patients

    Article • Cells, January 2022, MDPI AG

    Dr. Firas Kobeissy

  56. On-tissue spatially resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape

    Article • Cell Chemical Biology, January 2022, Elsevier

    Professor Isabelle Fournier, Dr. Firas Kobeissy

  57. Exploring the evidence for the effectiveness of health interventions for COVID-19 targeting migrants: a systematic review protocol

    Article • BMJ Open, December 2021, BMJ

    Paolo Giorgi Rossi, Dr. Firas Kobeissy

  58. Blood-based traumatic brain injury biomarkers – Clinical utilities and regulatory pathways in the United States, Europe and Canada

    Article • Expert Review of Molecular Diagnostics, November 2021, Taylor & Francis

    Dr. Firas Kobeissy

  59. Modulation of Neuro-Inflammatory Signals in Microglia by Plasma Prekallikrein and Neuronal Cell Debris

    Article • Frontiers in Pharmacology, November 2021, Frontiers

    Dr. Firas Kobeissy

  60. Correction to: Elevation of Pro‑inflammatory and Anti‑inflammatory Cytokines in Rat Serum after Acute Methamphetamine Treatment and Traumatic Brain Injury

    Article • Journal of Molecular Neuroscience, November 2021, Springer Science + Business Media

    Wael Mohamed, Dr. Firas Kobeissy

  61. Surfaceome Proteomic of Glioblastoma Revealed Potential Targets for Immunotherapy

    Article • Frontiers in Immunology, September 2021, Frontiers

    Professor Isabelle Fournier, Dr. Firas Kobeissy

  62. Elevation of Pro-inflammatory and Anti-inflammatory Cytokines in Rat Serum after Acute Methamphetamine Treatment and Traumatic Brain Injury

    Article • Journal of Molecular Neuroscience, September 2021, Springer Science + Business Media

    Dr. Firas Kobeissy

  63. Microvascular imaging ultrasound (MicroV) and power Doppler vascularization analysis in a pediatric population with early scrotal pain onset

    Article • Japanese Journal of Radiology, September 2021, Springer Science + Business Media

    Dr. Firas Kobeissy

  64. Long-term cognitive deficits after traumatic brain injury associated with microglia activation

    Article • Clinical Immunology, September 2021, Elsevier

    Dr. Firas Kobeissy

  65. Sweat metabolome and proteome: Recent trends in analytical advances and potential biological functions

    Article • Journal of Proteomics, August 2021, Elsevier

    Dr. Firas Kobeissy

  66. Neurotrauma investigation through spatial omics guided by mass spectrometry imaging: Target identification and clinical applications

    Article • Mass Spectrometry Reviews, July 2021, Wiley

    Professor Isabelle Fournier, Dr. Firas Kobeissy

  67. Bioinformatics Analysis of Allele Frequencies and Expression Patterns of ACE2, TMPRSS2 and FURIN in Different Populations and Susceptibility to SARS-CoV-2

    Article • Genes, July 2021, MDPI AG

    Dr. Firas Kobeissy

  68. National Trauma and Substance Use Disorders: A Slippery Slope in Lebanon

    Article • Substance Abuse, July 2021, SAGE Publications

    Dr. Firas Kobeissy

  69. Meningioma genomics: a therapeutic challenge for clinicians

    Article • Journal of Integrative Neuroscience, June 2021, IMR Press

    Dr. Firas Kobeissy

  70. Inflammatory Basis of Atherosclerosis: Modulation by Sex Hormones

    Article • Current Pharmaceutical Design, June 2021, Bentham Science Publishers

    Dr. Firas Kobeissy, Suzanne Nasser

  71. MS‐based glycomics and glycoproteomics methods enabling isomeric characterization

    Article • Mass Spectrometry Reviews, June 2021, Wiley

    Dr. Firas Kobeissy

  72. Potentiating Hemorrhage in a Periadolescent Rat Model of Closed-Head Traumatic Brain Injury Worsens Hyperexcitability but Not Behavioral Deficits

    Article • International Journal of Molecular Sciences, June 2021, MDPI AG

    Dr. Firas Kobeissy

  73. Beirut Ammonium Nitrate Blast: Analysis, Review, and Recommendations

    Article • Frontiers in Public Health, June 2021, Frontiers

    Dr. Firas Kobeissy

  74. In-depth proteomics analysis of sentinel lymph nodes from individuals with endometrial cancer

    Article • Cell Reports Medicine, June 2021, Elsevier

    Maxence Wisztorski, Professor Isabelle Fournier, Dr. Firas Kobeissy

  75. Searching for Novel Candidate Biomarkers of RLS in Blood by Proteomic Analysis

    Article • Nature and Science of Sleep, June 2021, Taylor & Francis

    Dr. Firas Kobeissy

  76. Corrigendum

    Article • The Neuroscientist, May 2021, SAGE Publications

    Dr. Firas Kobeissy

  77. SARS-CoV-2 and Stroke Characteristics

    Article • Stroke, May 2021, Wolters Kluwer Health

    Dr. Firas Kobeissy

  78. Repurposing of Acriflavine to Target Chronic Myeloid Leukemia Treatment

    Article • Current Medicinal Chemistry, April 2021, Bentham Science Publishers

    Dr. Firas Kobeissy

  79. Drug Repurposing: Promises of Edaravone Target Drug in Traumatic Brain Injury

    Article • Current Medicinal Chemistry, April 2021, Bentham Science Publishers

    Dr. Firas Kobeissy

  80. Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology

    Article • Frontiers in Cardiovascular Medicine, March 2021, Frontiers

    Dr. Firas Kobeissy

  81. A Bioinformatics Systems Biology Analysis of the Current Oral Proteomic Biomarkers and Implications for Diagnosis and Treatment of External Root Resorption

    Article • International Journal of Molecular Sciences, March 2021, MDPI AG

    Dr. Firas Kobeissy

  82. Combination of Angiotensin (1-7) Agonists and Convalescent Plasma as a New Strategy to Overcome Angiotensin Converting Enzyme 2 (ACE2) Inhibition for the Treatment of COVID-19

    Article • Frontiers in Medicine, March 2021, Frontiers

    Dr. Firas Kobeissy

  83. Analysis of the Neuroproteome Associated With Cell Therapy After Intranigral Grafting in a Mouse Model of Parkinson Disease

    Article • Frontiers in Neuroscience, March 2021, Frontiers

    Dr. Firas Kobeissy

  84. Visfatin: An emerging adipocytokine bridging the gap in the evolution of cardiovascular diseases

    Article • Journal of Cellular Physiology, February 2021, Wiley

    Dr Javad Sharifi Rad, Dr. Firas Kobeissy

  85. Identification of clinically relevant biomarkers of epileptogenesis — a strategic roadmap

    Article • Nature Reviews Neurology, February 2021, Springer Science + Business Media

    Dr. Firas Kobeissy

  86. Psychological distress experienced by physicians and nurses at a tertiary care center in Lebanon during the COVID-19 outbreak

    Article • Journal of Health Psychology, February 2021, SAGE Publications

    Dr. Firas Kobeissy

  87. Therapeutic anti-glioma effect of the combined action of PCSK inhibitor with the anti-tumoral factors secreted by Poly (I:C)-stimulated macrophages

    Article • Cancer Gene Therapy, January 2021, Springer Science + Business Media

    Professor Isabelle Fournier, Dr. Firas Kobeissy

  88. Neurological and Neuropsychological Changes Associated with SARS-CoV-2 Infection: New Observations, New Mechanisms

    Article • The Neuroscientist, January 2021, SAGE Publications

    Dr. Firas Kobeissy

  89. Acute ischemic stroke biomarkers: a new era with diagnostic promise?

    Article • Acute Medicine & Surgery, January 2021, Wiley

    Dr. Firas Kobeissy

  90. Thorough overview of ubiquitin C‐terminal hydrolase‐L1 and glial fibrillary acidic protein as tandem biomarkers recently cleared by US Food and Drug Administration for the evaluation of intracranial injuries among patients with traumatic brain injury

    Article • Acute Medicine & Surgery, January 2021, Wiley

    Dr. Firas Kobeissy

  91. C-Reactive Protein for Prediction or Early Detection of Pre-Eclampsia: A Systematic Review

    Article • Gynecologic and Obstetric Investigation, January 2021, Karger Publishers

    Dr. Firas Kobeissy

  92. Characterization of Traumatic Brain Injury Research in the Middle East and North Africa Region: A Systematic Review

    Article • Neuroepidemiology, January 2021, Karger Publishers

    Dr. Firas Kobeissy

  93. Dysregulation of Angiotensin Converting Enzyme 2 Expression and Function in Comorbid Disease Conditions Possibly Contributes to Coronavirus Infectious Disease 2019 Complication Severity

    Article • Molecular Pharmacology, January 2021, Elsevier

    Dr. Firas Kobeissy

  94. Depression following traumatic brain injury: a comprehensive overview

    Article • Reviews in the Neurosciences, December 2020, De Gruyter

    Dr. Firas Kobeissy

  95. Vascular Cells Proteome Associated with Bradykinin and Leptin Inflammation and Oxidative Stress Signals

    Article • Antioxidants, December 2020, MDPI AG

    Dr. Firas Kobeissy

  96. Advances in Cardiovascular Biomarker Discovery

    Article • Biomedicines, November 2020, MDPI AG

    Dr. Firas Kobeissy

  97. Secretome Analysis of Inductive Signals for BM-MSC Transdifferentiation into Salivary Gland Progenitors

    Article • International Journal of Molecular Sciences, November 2020, MDPI AG

    Dr. Firas Kobeissy

  98. Characteristics and Impact of U.S. Military Blast-Related Mild Traumatic Brain Injury: A Systematic Review

    Article • Frontiers in Neurology, November 2020, Frontiers

    Dr. Firas Kobeissy

  99. <p>Telepsychiatry in the Arab World: A Viewpoint Before and During COVID-19</p>

    Article • Neuropsychiatric Disease and Treatment, November 2020, Taylor & Francis

    Dr. Firas Kobeissy

  100. Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury

    Article • The Neuroscientist, October 2020, SAGE Publications

    Dr. Firas Kobeissy

  101. Preneoplastic lesions fimbria pan-proteomic studies establish the fimbriectomy benefit for BRCA1/2 patients and identify early diagnosis markers of HGSC

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Maxence Wisztorski, Professor Isabelle Fournier, Dr. Firas Kobeissy

  102. On-tissue spatially-resolved glycoproteomics guided by N-glycan imaging reveal global dysregulation of canine glioma glycoproteomic landscape

    Article • October 2020, Cold Spring Harbor Laboratory Press

    Professor Isabelle Fournier, Dr. Firas Kobeissy

  103. Epigenetic Studies Revealed a Ghost Proteome in PC1/3 KD Macrophages under Antitumoral Resistance Induced by IL-10

    Article • ACS Omega, October 2020, American Chemical Society (ACS)

    Professor Isabelle Fournier, Dr. Firas Kobeissy

  104. Traumatic Brain Injury: Oxidative Stress and Novel Anti-Oxidants Such as Mitoquinone and Edaravone

    Article • Antioxidants, October 2020, MDPI AG

    Dr. Firas Kobeissy

  105. Effects of the Oncoprotein PAX3-FOXO1 on Modulation of Exosomes Function and Protein Content: Implications on Oxidative Stress Protection and Enhanced Plasticity

    Article • Frontiers in Oncology, October 2020, Frontiers

    Dr. Firas Kobeissy

  106. The Role of Epac in Cancer Progression

    Article • International Journal of Molecular Sciences, September 2020, MDPI AG

    Dr. Firas Kobeissy

  107. Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study

    Article • EBioMedicine, September 2020, Elsevier

    Dr. Firas Kobeissy

  108. Protein Expression Analysis of an In Vitro Murine Model of Prostate Cancer Progression: Towards Identification of High-Potential Therapeutic Targets

    Article • Journal of Personalized Medicine, August 2020, MDPI AG

    Dr. Firas Kobeissy

  109. Novel therapeutic strategies for spinal osteosarcomas

    Article • Seminars in Cancer Biology, August 2020, Elsevier

    Dr Dina Johar, Dr. Firas Kobeissy

  110. <p>Prevalence of Eating Disorders Among Medical Students in a Lebanese Medical School: A Cross-Sectional Study</p>

    Article • Neuropsychiatric Disease and Treatment, August 2020, Taylor & Francis

    Dr. Firas Kobeissy

  111. Dysfunctional cerebrovascular tone contributes to cognitive impairment in a non-obese rat model of prediabetic challenge: Role of suppression of autophagy and modulation by anti-diabetic drugs

    Article • Biochemical Pharmacology, August 2020, Elsevier

    Dr. Firas Kobeissy

  112. Spinal sarcomas and immunity: An undervalued relationship

    Article • Seminars in Cancer Biology, August 2020, Elsevier

    Dr. Firas Kobeissy

  113. Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization

    Article • PLOS One, July 2020, PLOS

    Dr. Firas Kobeissy

  114. EPAC in Vascular Smooth Muscle Cells

    Article • International Journal of Molecular Sciences, July 2020, MDPI AG

    Dr. Firas Kobeissy

  115. The Mitochondria: A Target of Polyphenols in the Treatment of Diabetic Cardiomyopathy

    Article • International Journal of Molecular Sciences, July 2020, MDPI AG

    Dr. Firas Kobeissy

  116. Modulation of proteomic and inflammatory signals by Bradykinin in podocytes

    Article • Journal of Advanced Research, July 2020, Elsevier

    Dr. Firas Kobeissy

  117. Western diet aggravates neuronal insult in post-traumatic brain injury: Proposed pathways for interplay

    Article • EBioMedicine, July 2020, Elsevier

    Dr. Firas Kobeissy

  118. Serum Glycomics Profiling of Patients with Primary Restless Legs Syndrome Using LC–MS/MS

    Article • Journal of Proteome Research, June 2020, American Chemical Society (ACS)

    Dr. Firas Kobeissy

  119. The Role of a Proprotein Convertase Inhibitor in Reactivation of Tumor-Associated Macrophages and Inhibition of Glioma Growth

    Article • Molecular Therapy — Oncolytics, June 2020, Elsevier

    Professor Isabelle Fournier, Dr. Firas Kobeissy

  120. Protein Degradome of Spinal Cord Injury: Biomarkers and Potential Therapeutic Targets

    Article • Molecular Neurobiology, April 2020, Springer Science + Business Media

    Dr. Firas Kobeissy

  121. Circulating Brain Injury Exosomal Proteins following Moderate-to-Severe Traumatic Brain Injury: Temporal Profile, Outcome Prediction and Therapy Implications

    Article • Cells, April 2020, MDPI AG

    Dr. Firas Kobeissy

  122. Traumatic brain injury and methamphetamine: A double-hit neurological insult

    Article • Journal of the Neurological Sciences, April 2020, Elsevier

    Dr. Firas Kobeissy

  123. Editorial: Biomarkers in Neurology

    Article • Frontiers in Neurology, March 2020, Frontiers

    Wael Mohamed, Dr. Firas Kobeissy

  124. Gender‐biased kidney damage in mice following exposure to tobacco cigarette smoke: More protection in premenopausal females

    Article • Physiological Reports, January 2020, Wiley

    Dr. Firas Kobeissy

  125. Location of neonatal microglia drives small extracellular vesicles content and biological functions in vitro

    Article • Journal of Extracellular Vesicles, January 2020, Taylor & Francis

    Dr. Firas Kobeissy, Professor Isabelle Fournier

  126. P.867 Assessing cognitive behavioral therapy for insomnia in individuals with cannabis use disorder utilizing actigraphy and serum biomarkers

    Article • European Neuropsychopharmacology, December 2019, Elsevier

    Dr. Firas Kobeissy

  127. Transcriptomic profiling of trophoblast fusion using BeWo and JEG-3 cell lines

    Article • Molecular Human Reproduction, November 2019, Oxford University Press (OUP)

    Dr. Firas Kobeissy

  128. PC1/3 KD Macrophages Exhibit Resistance to the Inhibitory Effect of IL-10 and a Higher TLR4 Activation Rate, Leading to an Anti-Tumoral Phenotype

    Article • Cells, November 2019, MDPI AG

    Dr. Firas Kobeissy

  129. Novel Peptidomic Approach for Identification of Low and High Molecular Weight Tauopathy Peptides Following Calpain Digestion, and Primary Culture Neurotoxic Challenges

    Article • International Journal of Molecular Sciences, October 2019, MDPI AG

    Dr. Firas Kobeissy

  130. Proteomic Profiling of Rhabdomyosarcoma-Derived Exosomes Yield Insights into Their Functional Role in Paracrine Signaling

    Article • Journal of Proteome Research, August 2019, American Chemical Society (ACS)

    Dr. Firas Kobeissy

  131. Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry Imaging of Lipids in Experimental Model of Traumatic Brain Injury Detecting Acylcarnitines as Injury Related Markers

    Article • Analytical Chemistry, August 2019, American Chemical Society (ACS)

    Dr. Firas Kobeissy, Professor Isabelle Fournier

  132. Mapping Spatiotemporal Microproteomics Landscape in Experimental Model of Traumatic Brain Injury Unveils a link to Parkinson's Disease*

    Article • Molecular & Cellular Proteomics, August 2019, Elsevier

    Professor Isabelle Fournier, Dr. Firas Kobeissy

  133. Tobacco cigarette smoking exacerbates aortic calcification in an early stage of myocardial infarction in a female mouse model

    Article • Journal of Cellular Physiology, July 2019, Wiley

    Dr. Firas Kobeissy

  134. Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: Multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase

    Article • European Journal of Medicinal Chemistry, April 2019, Elsevier

    Perihan Elzahhar, Dr. Firas Kobeissy

  135. Enhanced setup for wired continuous long-term EEG monitoring in juvenile and adult rats: application for epilepsy and other disorders

    Article • BMC Neuroscience, March 2019, Springer Science + Business Media

    Dr. Firas Kobeissy

  136. Lestaurtinib (CEP-701) modulates the effects of early life hypoxic seizures on cognitive and emotional behaviors in immature rats

    Article • Epilepsy & Behavior, March 2019, Elsevier

    Dr. Firas Kobeissy

  137. Combination of drug and stem cells neurotherapy: Potential interventions in neurotrauma and traumatic brain injury

    Article • Neuropharmacology, February 2019, Elsevier

    Dr. Firas Kobeissy

  138. Functional pathways associated with human carotid atheroma: a proteomics analysis

    Article • Hypertension Research, January 2019, Springer Science + Business Media

    Dr. Firas Kobeissy

  139. Hydrogels for Advanced Stem Cell Therapies: A Biomimetic Materials Approach for Enhancing Natural Tissue Function

    Article • IEEE Reviews in Biomedical Engineering, January 2019, Institute of Electrical & Electronics Engineers (IEEE)

    Dr. Firas Kobeissy

  140. Psychiatric Disorders

    Article • January 2019, Springer Science + Business Media

    Dr. Firas Kobeissy

  141. Qualitative vs. Quantitative Methods in Psychiatric Research: Updated

    Article • January 2019, Springer Science + Business Media

    Dr. Firas Kobeissy

  142. Rodent Models of Methamphetamine Misuse: Mechanisms of Methamphetamine Action and Comparison of Different Rodent Paradigms

    Article • January 2019, Springer Science + Business Media

    Dr. Firas Kobeissy

  143. A shared comparison of diabetes mellitus and neurodegenerative disorders

    Article • Journal of Cellular Biochemistry, December 2018, Wiley

    Dr. Firas Kobeissy, Dr Dina Johar

  144. Novel biomarker signatures for idiopathic REM sleep behavior disorder

    Article • Neurology, October 2018, Wolters Kluwer Health

    Dr. Firas Kobeissy

  145. Transplantation of Embryonic Neural Stem Cells and Differentiated Cells in a Controlled Cortical Impact (CCI) Model of Adult Mouse Somatosensory Cortex

    Article • Frontiers in Neurology, October 2018, Frontiers

    Dr. Firas Kobeissy

  146. Delayed sleep phase syndrome and bipolar disorder: Pathogenesis and available common biomarkers

    Article • Sleep Medicine Reviews, October 2018, Elsevier

    Dr. Firas Kobeissy

  147. LC-MS/MS glycomics of idiopathic rapid eye movement sleep behavior disorder

    Article • Electrophoresis, September 2018, Wiley

    Dr. Firas Kobeissy

  148. Lipid Changes Associated with Traumatic Brain Injury Revealed by 3D MALDI-MSI

    Article • Analytical Chemistry, August 2018, American Chemical Society (ACS)

    Dr. Firas Kobeissy, Professor Isabelle Fournier

  149. Temporally and spatially-resolved microproteomics and MALDI MSI lipidomic analysis for traumatic brain injury biomarker identification

    Article • Journal of Biotechnology, August 2018, Elsevier

    Professor Isabelle Fournier, Dr. Firas Kobeissy

  150. SLC35B4, an Inhibitor of Gluconeogenesis, Responds to Glucose Stimulation and Downregulates Hsp60 among Other Proteins in HepG2 Liver Cell Lines

    Article • Molecules, June 2018, MDPI AG

    Dr. Firas Kobeissy

  151. Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms

    Article • Progress in Neurobiology, June 2018, Elsevier

    Dr. Firas Kobeissy

  152. Extracellular vesicles: pathogenetic, diagnostic and therapeutic value in traumatic brain injury

    Article • Expert Review of Proteomics, April 2018, Taylor & Francis

    Dr. Firas Kobeissy

  153. Insomnia in hospitalized psychiatric patients: prevalence and associated factors

    Article • April 2018, Dove Medical Press

    Dr. Firas Kobeissy

  154. Erythropoietin Does Not Alter Serum Profiles of Neuronal and Axonal Biomarkers After Traumatic Brain Injury: Findings From the Australian EPO-TBI Clinical Trial

    Article • Critical Care Medicine, April 2018, Wolters Kluwer Health

    Dr. Firas Kobeissy

  155. Paclitaxel treatment and PC1/3 knockdown in macrophages is a promising anti-glioma strategy as revealed by proteomics and cytotoxicity studies

    Article • Molecular & Cellular Proteomics, March 2018, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Isabelle Fournier, Maxence Wisztorski, Dr. Firas Kobeissy

  156. Docosahexaenoic acid (DHA) enhances the therapeutic potential of neonatal neural stem cell transplantation post—Traumatic brain injury

    Article • Behavioural Brain Research, March 2018, Elsevier

    Dr. Firas Kobeissy

  157. Correction to: Protein Biomarkers and Neuroproteomics Characterization of Microvesicles/Exosomes from Human Cerebrospinal Fluid Following Traumatic Brain Injury

    Article • Molecular Neurobiology, January 2018, Springer Science + Business Media

    Dr. Firas Kobeissy

  158. Coupling Large-Scale Omics Data for Deciphering Systems Complexity

    Article • January 2018, Springer Science + Business Media

    Dr. Firas Kobeissy

  159. Genomic alterations during p53-dependent apoptosis induced by γ-irradiation of Molt-4 leukemia cells

    Article • PLOS One, December 2017, PLOS

    Dr. Firas Kobeissy

  160. Characterization and assessment of potential microRNAs involved in phosphate-induced aortic calcification

    Article • Journal of Cellular Physiology, November 2017, Wiley

    Dr. Firas Kobeissy

  161. Spatially-Resolved Top-down Proteomics Bridged to MALDI MS Imaging Reveals the Molecular Physiome of Brain Regions

    Article • Molecular & Cellular Proteomics, November 2017, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Isabelle Fournier, Maxence Wisztorski, Dr. Firas Kobeissy

  162. Proteome profiling in the aorta and kidney of type 1 diabetic rats

    Article • PLOS One, November 2017, PLOS

    Dr. Firas Kobeissy

  163. Glycosylation Changes in Brain Cancer

    Article • ACS Chemical Neuroscience, November 2017, American Chemical Society (ACS)

    Dr. Firas Kobeissy

  164. The diagnostic values of UCH-L1 in traumatic brain injury: A meta-analysis

    Article • Brain Injury, October 2017, Taylor & Francis

    Farhad Shokraneh, Dr. Firas Kobeissy

  165. Traumatic brain injury, diabetic neuropathy and altered-psychiatric health: The fateful triangle

    Article • Medical Hypotheses, October 2017, Elsevier

    Dr. Firas Kobeissy

  166. Erratum to: Degradation of βII-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions

    Article • Molecular Neurobiology, September 2017, Springer Science + Business Media

    Dr. Firas Kobeissy

  167. Preclinical modelling of militarily relevant traumatic brain injuries: Challenges and recommendations for future directions

    Article • Brain Injury, July 2017, Taylor & Francis

    Dr. Firas Kobeissy, Ibolja Cernak

  168. Combined Mass Spectrometry Imaging and Top-down Microproteomics Reveals Evidence of a Hidden Proteome in Ovarian Cancer

    Article • EBioMedicine, July 2017, Elsevier

    Professor Isabelle Fournier, Maxence Wisztorski, Dr. Firas Kobeissy

  169. RhoA Inhibitor Treatment At Acute Phase of Spinal Cord Injury May Induce Neurite Outgrowth and Synaptogenesis

    Article • Molecular & Cellular Proteomics, June 2017, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Isabelle Fournier, Dr. Firas Kobeissy

  170. Multitargeted Flavonoid Inhibition of the Pathogenic Bacterium Staphylococcus aureus: A Proteomic Characterization

    Article • Journal of Proteome Research, May 2017, American Chemical Society (ACS)

    Dr. Firas Kobeissy

  171. Thyroxine (T4) Transfer from Blood to Cerebrospinal Fluid in Sheep Isolated Perfused Choroid Plexus: Role of Multidrug Resistance-Associated Proteins and Organic Anion Transporting Polypeptides

    Article • Frontiers in Neurology, May 2017, Frontiers

    Dr. Firas Kobeissy, Wael Mohamed

  172. Risk of obstructive sleep apnea and excessive daytime sleepiness in hospitalized psychiatric patients

    Article • April 2017, Dove Medical Press

    Dr. Firas Kobeissy

  173. The Application of Proteomics to Traumatic Brain and Spinal Cord Injuries

    Article • Current Neurology and Neuroscience Reports, March 2017, Springer Science + Business Media

    Dr. Firas Kobeissy

  174. Chemosensitivity of U251 Cells to the Co-treatment of D-Penicillamine and Copper: Possible Implications on Wilson Disease Patients

    Article • Frontiers in Molecular Neuroscience, January 2017, Frontiers

    Dr. Firas Kobeissy

  175. Novel Bioinformatics–Based Approach for Proteomic Biomarkers Prediction of Calpain-2 & Caspase-3 Protease Fragmentation: Application to βII-Spectrin Protein

    Article • Scientific Reports, January 2017, Springer Science + Business Media

    Dr. Firas Kobeissy

  176. Glycoproteins Enrichment and LC-MS/MS Glycoproteomics in Central Nervous System Applications

    Article • January 2017, Springer Science + Business Media

    Dr. Firas Kobeissy

  177. Acute Exposure to Cigarette Smoking Followed by Myocardial Infarction Aggravates Renal Damage in an In Vivo Mouse Model

    Article • Oxidative Medicine and Cellular Longevity, January 2017, Hindawi Publishing Corporation

    Kazem Zibara, Dr. Firas Kobeissy, Dr Ali Nehme, Emna Abidi

  178. Functional, Cellular, and Molecular Remodeling of the Heart under Influence of Oxidative Cigarette Tobacco Smoke

    Article • Oxidative Medicine and Cellular Longevity, January 2017, Hindawi Publishing Corporation

    Dr. Firas Kobeissy, Emna Abidi

  179. AutoDock and AutoDockTools for Protein-Ligand Docking: Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1(BACE1) as a Case Study

    Article • January 2017, Springer Science + Business Media

    Dr. Firas Kobeissy

  180. Biofluid Proteomics and Biomarkers in Traumatic Brain Injury

    Article • January 2017, Springer Science + Business Media

    Dr. Firas Kobeissy

  181. Degradomics in Neurotrauma: Profiling Traumatic Brain Injury

    Article • January 2017, Springer Science + Business Media

    Dr. Firas Kobeissy

  182. Effect of Second-Hand Tobacco Smoke on the Nitration of Brain Proteins: A Systems Biology and Bioinformatics Approach

    Article • January 2017, Springer Science + Business Media

    Dr. Firas Kobeissy

  183. Efficient and Accurate Algorithm for Cleaved Fragments Prediction (CFPA) in Protein Sequences Dataset Based on Consensus and Its Variants: A Novel Degradomics Prediction Application

    Article • January 2017, Springer Science + Business Media

    Dr. Firas Kobeissy

  184. Neuroproteomics Studies: Challenges and Updates

    Article • January 2017, Springer Science + Business Media

    Dr. Firas Kobeissy

  185. The Emerging Role of Proteomics in Precision Medicine: Applications in Neurodegenerative Diseases and Neurotrauma

    Article • January 2017, Springer Science + Business Media

    Dr. Firas Kobeissy

  186. Neuroproteomics and Systems Biology Approach to Identify Temporal Biomarker Changes Post Experimental Traumatic Brain Injury in Rats

    Article • Frontiers in Neurology, November 2016, Frontiers

    Dr. Firas Kobeissy

  187. Cigarette Smoking-Induced Cardiac Hypertrophy, Vascular Inflammation and Injury Are Attenuated by Antioxidant Supplementation in an Animal Model

    Article • Frontiers in Pharmacology, November 2016, Frontiers

    Dr. Firas Kobeissy

  188. Evaluation of non-supervised MALDI mass spectrometry imaging combined with microproteomics for glioma grade III classification

    Article • Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, November 2016, Elsevier

    Professor Isabelle Fournier, Maxence Wisztorski, Dr. Firas Kobeissy

  189. Epidemiology and clinical characteristics of traumatic brain injury in Lebanon

    Article • Medicine, November 2016, Wolters Kluwer Health

    Jawad Fares, Dr. Firas Kobeissy

  190. Deciphering the Role of Emx1 in Neurogenesis: A Neuroproteomics Approach

    Article • Frontiers in Molecular Neuroscience, October 2016, Frontiers

    Dr. Firas Kobeissy

  191. Traumatic Brain Injury and Blood-Brain Barrier Cross-Talk

    Article • CNS & Neurological Disorders - Drug Targets, October 2016, Bentham Science Publishers

    Dr. Firas Kobeissy

  192. Restless leg syndrome in hospitalized psychiatric patients in Lebanon: a pilot study

    Article • October 2016, Dove Medical Press

    Dr. Firas Kobeissy

  193. The kinetics of angiotensin-I metabolism in human carotid atheroma: An emerging role for angiotensin (1–7)

    Article • Vascular Pharmacology, October 2016, Elsevier

    Dr Ali Nehme, Dr. Firas Kobeissy

  194. Proteomic Analysis of the Spatio-temporal Based Molecular Kinetics of Acute Spinal Cord Injury Identifies a Time- and Segment-specific Window for Effective Tissue Repair

    Article • Molecular & Cellular Proteomics, June 2016, American Society for Biochemistry & Molecular Biology (ASBMB)

    Professor Isabelle Fournier, Maxence Wisztorski, Dr. Firas Kobeissy

  195. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury

    Article • Scientific Reports, June 2016, Springer Science + Business Media

    Dr. Firas Kobeissy

  196. Pregnancy outcomes in Lebanese women with multiple sclerosis (the LeMS study): a prospective multicentre study

    Article • BMJ Open, May 2016, BMJ

    Jawad Fares, Dr. Firas Kobeissy

  197. The Effect of Chronic Methamphetamine Exposure on the Hippocampal and Olfactory Bulb Neuroproteomes of Rats

    Article • PLOS One, April 2016, PLOS

    Dr. Firas Kobeissy

  198. Glycosylation and other PTMs alterations in neurodegenerative diseases: Current status and future role in neurotrauma

    Article • Electrophoresis, April 2016, Wiley

    Dr. Firas Kobeissy

  199. Assessment of Serum UCH-L1 and GFAP in Acute Stroke Patients

    Article • Scientific Reports, April 2016, Springer Science + Business Media

    Dr. Firas Kobeissy

  200. Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment

    Article • Electrophoresis, March 2016, Wiley

    Dr. Firas Kobeissy, Jawad Fares

  201. Primary versus castration-resistant prostate cancer: modeling through novel murine prostate cancer cell lines

    Article • Oncotarget, March 2016, Impact Journals, LLC

    Dr. Firas Kobeissy

  202. Inflammation and Elevation of Interleukin-12p40 in Patients with Schizophrenia

    Article • Frontiers in Molecular Neuroscience, March 2016, Frontiers

    Jawad Fares, Dr. Firas Kobeissy

  203. RYR2, PTDSS1 and AREG genes are implicated in a Lebanese population-based study of copy number variation in autism

    Article • Scientific Reports, January 2016, Springer Science + Business Media

    Dr. Firas Kobeissy

  204. Application of Systems Biology to Neuroproteomics: The Path to Enhanced Theranostics in Traumatic Brain Injury

    Article • January 2016, Springer Science + Business Media

    Dr. Firas Kobeissy

  205. Postnatal Neural Stem Cells in Treating Traumatic Brain Injury

    Article • January 2016, Springer Science + Business Media

    Dr. Firas Kobeissy

  206. Role of Systems Biology in Brain Injury Biomarker Discovery: Neuroproteomics Application

    Article • January 2016, Springer Science + Business Media

    Dr. Firas Kobeissy

  207. Metformin and Ara-a Effectively Suppress Brain Cancer by Targeting Cancer Stem/Progenitor Cells

    Article • Frontiers in Neuroscience, November 2015, Frontiers

    Dr. Firas Kobeissy

  208. Mechanical stretch-induced vascular hypertrophy occurs through modulation of leptin synthesis-mediated ROS formation and GATA-4 nuclear translocation

    Article • Frontiers in Pharmacology, October 2015, Frontiers

    Dr. Firas Kobeissy

  209. Molecular Consequences of Proprotein Convertase 1/3 (PC1/3) Inhibition in Macrophages for Application to Cancer Immunotherapy: A Proteomic Study

    Article • Molecular & Cellular Proteomics, September 2015, American Society for Biochemistry & Molecular Biology (ASBMB)

    Maxence Wisztorski, Professor Isabelle Fournier, Pr Serge Nataf, Dr. Firas Kobeissy

  210. Culture of PC12 neuronal cells in GelMA hydrogel for brain tissue engineering

    Article • September 2015, Institute of Electrical & Electronics Engineers (IEEE)

    Dr. Firas Kobeissy

  211. Correction: Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment

    Article • PLOS One, August 2015, PLOS

    Dr. Firas Kobeissy

  212. Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment

    Article • PLOS One, June 2015, PLOS

    Dr. Firas Kobeissy

  213. Cleaved Fragments Prediction Algorithm (CFPA) application to calpain and caspase in apoptosis and necrotic cell death

    Article • May 2015, Institute of Electrical & Electronics Engineers (IEEE)

    Dr. Firas Kobeissy

  214. Proteomics studies in inner ear disorders: pathophysiology and biomarkers

    Article • Expert Review of Proteomics, March 2015, Taylor & Francis

    Marc Bassim, Dr. Firas Kobeissy

  215. Biomarker Identification in Psychiatric Disorders

    Article • Journal of Psychiatric Practice, January 2015, Wolters Kluwer Health

    Dr. Firas Kobeissy

  216. Autoantibodies in traumatic brain injury and central nervous system trauma

    Article • Neuroscience, December 2014, Elsevier

    Dr. Firas Kobeissy

  217. Nanotheragnostic Applications for Ischemic and Hemorrhagic Strokes: Improved Delivery for a Better Prognosis

    Article • Current Neurology and Neuroscience Reports, November 2014, Springer Science + Business Media

    Dr. Firas Kobeissy

  218. Neuro-proteomics and Neuro-systems Biology in the Quest of TBI Biomarker Discovery

    Article • October 2014, Taylor & Francis

    Dr. Firas Kobeissy

  219. Protein Biomarkers in Traumatic Brain Injury: An Omics Approach

    Article • October 2014, Taylor & Francis

    Dr. Firas Kobeissy

  220. CSF and Plasma Amyloid-β Temporal Profiles and Relationships with Neurological Status and Mortality after Severe Traumatic Brain Injury

    Article • Scientific Reports, October 2014, Springer Science + Business Media

    Dr. Firas Kobeissy

  221. Minor and Repetitive Head Injury

    Article • October 2014, Springer Science + Business Media

    Dr. Firas Kobeissy

  222. Degradation of βII-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions

    Article • Molecular Neurobiology, October 2014, Springer Science + Business Media

    Dr. Firas Kobeissy

  223. Recent updates on drug abuse analyzed by neuroproteomics studies: Cocaine, Methamphetamine and MDMA

    Article • Translational Proteomics, June 2014, Elsevier

    Dr. Firas Kobeissy

  224. Human Traumatic Brain Injury Induces Autoantibody Response against Glial Fibrillary Acidic Protein and Its Breakdown Products

    Article • PLOS One, March 2014, PLOS

    Dr. Firas Kobeissy

  225. A neuroproteomic and systems biology analysis of rat brain post intracerebral hemorrhagic stroke

    Article • Brain Research Bulletin, March 2014, Elsevier

    Dr. Firas Kobeissy

  226. Post-Genomics Nanotechnology Is Gaining Momentum: Nanoproteomics and Applications in Life Sciences

    Article • OMICS A Journal of Integrative Biology, February 2014, Mary Ann Liebert Inc

    Dr. Firas Kobeissy

  227. Stem cells in neuroinjury and neurodegenerative disorders: challenges and future neurotherapeutic prospects

    Article • Neural Regeneration Research, January 2014, Medknow

    Dr. Firas Kobeissy

  228. Bioinformatics Approach to Understanding Interacting Pathways in Neuropsychiatric Disorders

    Article • January 2014, Springer Science + Business Media

    Dr. Firas Kobeissy

  229. Uses and challenges of bioinformatic tools in mass spectrometric-based proteomic brain perturbation studies

    Article • International Journal of Bioinformatics Research and Applications, January 2014, Inderscience Publishers

    Dr. Firas Kobeissy

  230. Different expression of ubiquitin C-terminal hydrolase-L1 and αII-spectrin in ischemic and hemorrhagic stroke: Potential biomarkers in diagnosis

    Article • Brain Research, December 2013, Elsevier

    Dr. Firas Kobeissy

  231. Combining Biochemical and Imaging Markers to Improve Diagnosis and Characterization of Mild Traumatic Brain Injury in the Acute Setting: Results from a Pilot Study

    Article • PLOS One, November 2013, PLOS

    Dr. Firas Kobeissy

  232. CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat

    Article • Neurobiology of Disease, October 2013, Elsevier

    Dr. Firas Kobeissy

  233. Biomarkers Track Damage after Graded Injury Severity in a Rat Model of Penetrating Brain Injury

    Article • Journal of Neurotrauma, July 2013, Mary Ann Liebert Inc

    Dr. Firas Kobeissy

  234. The Challenge of Mild Traumatic Brain Injury: Role of Biochemical Markers in Diagnosis of Brain Damage

    Article • Medicinal Research Reviews, June 2013, Wiley

    Dr. Firas Kobeissy

  235. An updated overview of animal models in neuropsychiatry

    Article • Neuroscience, June 2013, Elsevier

    Dr. Firas Kobeissy

  236. Overpressure blast-wave induced brain injury elevates oxidative stress in the hypothalamus and catecholamine biosynthesis in the rat adrenal medulla

    Article • Neuroscience Letters, June 2013, Elsevier

    Dr. Firas Kobeissy

  237. Biomarkers in psychiatry: how close are we?

    Article • Frontiers in Psychiatry, January 2013, Frontiers

    Dr. Firas Kobeissy

  238. Assessing neuro-systemic & behavioral components in the pathophysiology of blast-related brain injury

    Article • Frontiers in Neurology, January 2013, Frontiers

    Walid Yassin, Dr. Firas Kobeissy

  239. Pilot Study Using Proteomics to Identify Predictive Biomarkers of Necrotizing Enterocolitis from Buccal Swabs in Very Low Birth Weight Infants

    Article • Neonatology, January 2013, Karger Publishers

    Dr. Firas Kobeissy

  240. Editorial

    Article • Electrophoresis, December 2012, Wiley

    Dr. Firas Kobeissy

  241. In vitro MS-based proteomic analysis and absolute quantification of neuronal-glial injury biomarkers in cell culture system

    Article • Electrophoresis, December 2012, Wiley

    Dr. Firas Kobeissy

  242. Microbial cell components induced tolerance to flagellin-stimulated inflammation through Toll-like receptor pathways in intestinal epithelial cells

    Article • Cytokine, December 2012, Elsevier

    Dr. Firas Kobeissy

  243. Proteomic analysis and brain-specific systems biology in a rodent model of penetrating ballistic-like brain injury

    Article • Electrophoresis, December 2012, Wiley

    Dr. Firas Kobeissy

  244. Neuroproteomics approach and neurosystems biology analysis: ROCK inhibitors as promising therapeutic targets in neurodegeneration and neurotrauma

    Article • Electrophoresis, November 2012, Wiley

    Dr. Firas Kobeissy

  245. Identification of Proteins Sensitive to Thermal Stress in Human Neuroblastoma and Glioma Cell Lines

    Article • PLOS One, November 2012, PLOS

    Dr. Firas Kobeissy

  246. Global Renal Gene Expression Profiling Analysis in B2-Kinin Receptor Null Mice: Impact of Diabetes

    Article • PLOS One, September 2012, PLOS

    Dr. Firas Kobeissy

  247. Anesthetic Management in Body Countouring Surgery

    Article • Journal of Anesthesia & Clinical Research, January 2012, OMICS Publishing Group

    Dr. Firas Kobeissy

  248. Systems Biology, Bioinformatics, and Biomarkers in Neuropsychiatry

    Article • Frontiers in Neuroscience, January 2012, Frontiers

    Dr. Firas Kobeissy

  249. Methods in Drug Abuse Models: Comparison of Different Models of Methamphetamine Paradigms

    Article • December 2011, Springer Science + Business Media

    Dr. Firas Kobeissy, Drake Morgan

  250. Methods in Tobacco Abuse: Proteomic Changes Following Second-Hand Smoke Exposure

    Article • December 2011, Springer Science + Business Media

    Dr. Firas Kobeissy

  251. Qualitative Versus Quantitative Methods in Psychiatric Research

    Article • December 2011, Springer Science + Business Media

    Dr. Firas Kobeissy

  252. Animal Models of Self-Injurious Behaviour: An Overview

    Article • December 2011, Springer Science + Business Media

    Dr. Firas Kobeissy

  253. Protein Biomarkers for Traumatic and Ischemic Brain Injury: From Bench to Bedside

    Article • Translational Stroke Research, December 2011, Springer Science + Business Media

    Dr. Firas Kobeissy

  254. Identification of tyrosine nitration in UCH-L1 and GAPDH

    Article • Electrophoresis, June 2011, Wiley

    Dr. Firas Kobeissy

  255. Leveraging Biomarker Platforms and Systems Biology for Rehabilomics and Biologics Effectiveness Research

    Article • PM&R, June 2011, Wiley

    Dr. Firas Kobeissy

  256. Engineered Multifunctional Nanotools for Biological Applications

    Article • January 2011, Springer Science + Business Media

    Dr. Firas Kobeissy

  257. Resolving the Negative Data Publication Dilemma in Translational Stroke Research

    Article • Translational Stroke Research, December 2010, Springer Science + Business Media

    Dr. Firas Kobeissy

  258. Dual Vulnerability of Tau to Calpains and Caspase-3 Proteolysis Under Neurotoxic and Neurodegenerative Conditions

    Article • ASN NEURO, November 2010, SAGE Publications

    Dr. Firas Kobeissy

  259. Pharmacological Therapeutics for Detoxification in Addictive Disorders

    Article • July 2010, Wiley

    Dr. Firas Kobeissy

  260. Food Addiction and Obesity: Evidence from Bench to Bedside

    Article • Journal of Psychoactive Drugs, June 2010, Taylor & Francis

    Dr. Firas Kobeissy

  261. Preadolescent tobacco smoke exposure leads to acute nicotine dependence but does not affect the rewarding effects of nicotine or nicotine withdrawal in adulthood in rats

    Article • Pharmacology Biochemistry and Behavior, June 2010, Elsevier

    Dr. Firas Kobeissy

  262. Acute NMDA toxicity in cultured rat cerebellar granule neurons is accompanied by autophagy induction and late onset autophagic cell death phenotype

    Article • BMC Neuroscience, February 2010, Springer Science + Business Media

    Dr. Firas Kobeissy

  263. Ubiquitin C-terminal hydrolase-L1 as a biomarker for ischemic and traumatic brain injury in rats

    Article • European Journal of Neuroscience, February 2010, Wiley

    Dr. Firas Kobeissy

  264. Methods in Systems Biology of Experimental Methamphetamine Drug Abuse

    Article • January 2010, Springer Science + Business Media

    Dr. Firas Kobeissy

  265. Systems Biology and Theranostic Approach to Drug Discovery and Development to Treat Traumatic Brain Injury

    Article • January 2010, Springer Science + Business Media

    Dr. Firas Kobeissy

  266. Methamphetamine- and Trauma-Induced Brain Injuries: Comparative Cellular and Molecular Neurobiological Substrates

    Article • Biological Psychiatry, July 2009, Elsevier

    Dr. Firas Kobeissy

  267. Gliotypic Neural Stem Cells Transiently Adopt Tumorigenic Properties During Normal Differentiation

    Article • Stem Cells, February 2009, Wiley

    Dr. Firas Kobeissy

  268. Calmodulin-Binding Proteome in the Brain

    Article • January 2009, Springer Science + Business Media

    Dr. Firas Kobeissy

  269. Methods in Drug Abuse Neuroproteomics: Methamphetamine Psychoproteome

    Article • January 2009, Springer Science + Business Media

    Dr. Firas Kobeissy

  270. Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation

    Article • PROTEOMICS - CLINICAL APPLICATIONS, October 2008, Wiley

    Dr. Firas Kobeissy

  271. Psychoproteomic Analysis of Rat Cortex Following Acute Methamphetamine Exposure

    Article • Journal of Proteome Research, May 2008, American Chemical Society (ACS)

    Dr. Firas Kobeissy

  272. Psychiatric research: psychoproteomics, degradomics and systems biology

    Article • Expert Review of Proteomics, April 2008, Taylor & Francis

    Dr. Firas Kobeissy

  273. Changes in leptin, ghrelin, growth hormone and neuropeptide-Y after an acute model of MDMA and methamphetamine exposure in rats

    Article • Addiction Biology, March 2008, Wiley

    Dr. Firas Kobeissy

  274. Speed, Cocaine, and Other Psychostimulants Death Rates

    Article • The American Journal of Cardiology, October 2007, Elsevier

    Dr. Firas Kobeissy

  275. Performance Enhancing, Non-Prescription Use of Ritalin

    Article • Journal of Addictive Diseases, August 2007, Taylor & Francis

    Dr. Firas Kobeissy

  276. Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA

    Article • Acta Neuropathologica, July 2007, Springer Science + Business Media

    Dr. Firas Kobeissy

  277. Calpain-Mediated Collapsin Response Mediator Protein-1, -2, And -4 Proteolysis after Neurotoxic And Traumatic Brain Injury

    Article • Journal of Neurotrauma, March 2007, Mary Ann Liebert Inc

    Dr. Firas Kobeissy

  278. Application of the data mining techniques to the systems biology of neuritogenesis

    Article • Optimization Methods and Software, February 2007, Taylor & Francis

    Dr. Firas Kobeissy

  279. Novel neuroproteomic approaches to studying traumatic brain injury

    Article • January 2007, Elsevier

    Dr. Firas Kobeissy

  280. Ecstasy Toxicity

    Article • Journal of Addictive Diseases, November 2006, Taylor & Francis

    Dr. Firas Kobeissy

  281. Performance Enhancement and Adverse Consequences of MDMA

    Article • Journal of Addictive Diseases, November 2006, Taylor & Francis

    Dr. Firas Kobeissy

  282. Calpain- and caspase-mediated αII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure

    Article • The International Journal of Neuropsychopharmacology, August 2006, Oxford University Press (OUP)

    Dr. Firas Kobeissy

  283. Novel Differential Neuroproteomics Analysis of Traumatic Brain Injury in Rats

    Article • Molecular & Cellular Proteomics, June 2006, American Society for Biochemistry & Molecular Biology (ASBMB)

    Dr. Firas Kobeissy

  284. Direct Rho-associated kinase inhibiton induces cofilin dephosphorylation and neurite outgrowth in PC-12 cells

    Article • Cellular & Molecular Biology Letters, January 2006, De Gruyter

    Dr. Firas Kobeissy

  285. Neuroproteomics in neurotrauma

    Article • Mass Spectrometry Reviews, January 2006, Wiley

    Dr. Firas Kobeissy

  286. Concurrent calpain and caspase-3 mediated proteolysis of αII-spectrin and tau in rat brain after methamphetamine exposure: A similar profile to traumatic brain injury

    Article • Life Sciences, December 2005, Elsevier

    Dr. Firas Kobeissy

  287. A Multidimensional Differential Proteomic Platform Using Dual-Phase Ion-Exchange Chromatography−Polyacrylamide Gel Electrophoresis/Reversed-Phase Liquid Chromatography Tandem Mass Spectrometry

    Article • Analytical Chemistry, August 2005, American Chemical Society (ACS)

    Dr. Firas Kobeissy

  288. Rapid Discovery of Putative Protein Biomarkers of Traumatic Brain Injury by SDS–PAGE–Capillary Liquid Chromatography–Tandem Mass Spectrometry

    Article • Journal of Neurotrauma, June 2005, Mary Ann Liebert Inc

    Dr. Firas Kobeissy

  289. Article • Clinical and Molecular Allergy, January 2004, Springer Science + Business Media

    Dr. Firas Kobeissy

  290. Proteomics Studies of Traumatic Brain Injury

    Article • January 2004, Elsevier

    Dr. Firas Kobeissy

  291. SOME IMMUNOLOGICAL ASPECTS OF PATIENTS WITH RHINITIS IN LEBANON

    Article • Immunopharmacology and Immunotoxicology, January 2002, Taylor & Francis

    Dr. Firas Kobeissy

  292. Major histocompatibility complex class I and II antigens frequencies in selected groups of Lebanese

    Article • Transplantation Proceedings, August 2001, Elsevier

    Dr. Firas Kobeissy